CTLA-4 blockade-based immunotherapy for prostate cancer.

被引：0
|
作者：
Fong, L [1 ]
Rini, B [1 ]
Kavanaugh, B [1 ]
Small, E [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2590
引用
收藏
页码：185S / 185S
页数：1
相关论文
共 50 条
  • [1] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Satoshi Wada
    Christopher M Jackson
    Kiyoshi Yoshimura
    Hung-Rong Yen
    Derese Getnet
    Timothy J Harris
    Monica V Goldberg
    Tullia C Bruno
    Joseph F Grosso
    Nicholas Durham
    George J Netto
    Drew M Pardoll
    Charles G Drake
    Journal of Translational Medicine, 11
  • [2] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Wada, Satoshi
    Jackson, Christopher M.
    Yoshimura, Kiyoshi
    Yen, Hung-Rong
    Getnet, Derese
    Harris, Timothy J.
    Goldberg, Monica V.
    Bruno, Tullia C.
    Grosso, Joseph F.
    Durham, Nicholas
    Netto, George J.
    Pardoll, Drew M.
    Drake, Charles G.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [3] CTLA-4 blockade and the renaissance of cancer immunotherapy
    Mocellin, Simone
    Nitti, Donato
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 187 - 196
  • [4] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Xuexiang Du
    Fei Tang
    Mingyue Liu
    Juanjuan Su
    Yan Zhang
    Wei Wu
    Martin Devenport
    Christopher A Lazarski
    Peng Zhang
    Xu Wang
    Peiying Ye
    Changyu Wang
    Eugene Hwang
    Tinghui Zhu
    Ting Xu
    Pan Zheng
    Yang Liu
    Cell Research, 2018, 28 : 416 - 432
  • [5] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Du, Xuexiang
    Tang, Fei
    Liu, Mingyue
    Su, Juanjuan
    Zhang, Yan
    Wu, Wei
    Devenport, Martin
    Lazarski, Christopher A.
    Zhang, Peng
    Wang, Xu
    Ye, Peiying
    Wang, Changyu
    Hwang, Eugene
    Zhu, Tinghui
    Xu, Ting
    Zheng, Pan
    Liu, Yang
    CELL RESEARCH, 2018, 28 (04) : 416 - 432
  • [6] Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
    Kuang Youlin
    Zhang Li
    Weng Xiaodong
    Liu Xiuheng
    Zhu Hengchen
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [7] A reappraisal of CTLA-4 checkpoint blockade hypothesis in cancer immunotherapy
    Du, Xuexiang
    Tang, Fei
    Liu, Mingyue
    Zheng, Pan
    Liu, Yang
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 : 59 - 59
  • [8] Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade
    Hurwitz, AA
    Foster, BA
    Kwon, ED
    Truong, T
    Choi, EM
    Greenberg, NM
    Burg, MB
    Allison, JP
    CANCER RESEARCH, 2000, 60 (09) : 2444 - 2448
  • [9] A phase I trial of combination immunotherapy with CTLA-4 blockade and GM-CSF in hormone-refractory prostate cancer.
    Fong, L.
    Kavanagh, B.
    Rini, B. I.
    Shaw, V.
    Weinberg, V.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 102S - 102S
  • [10] Synergistic effects of αCTLA-4 and radiotherapy in the treatment of prostate cancer.
    Johnson, Lisa D. S.
    Beckham, Wayne A.
    Russell, Gordon H.
    Lum, Julian J.
    Vlachaki, Maria T.
    CANCER RESEARCH, 2013, 73
12345